Companies / ATX

AMPLIA THERAPEUTICS LIMITED

ASX:ATXPharmaceuticals, Biotechnology & Life Sciences
513.3M shares on issueASX (delayed) · snapshot 11 Sept 2026620.5M fully diluted+20.9% if every option and right converts$0.12price · delayed$61.6Mmarket cap · indicative

Today’s holders own 82.7% of what they think they own, once every option and right converts.

Moderate
Dilution risk

Share count grew 87% in 24 months; runway 4–8 quarters; 2 cash raises in 24 months

MinimalVery high
Absolute levels — not a ranking against other companies.
Cash runway5.4 quarters of funding
Share-count growth (24m)86.8%
Raise cadence (24m)2 cash raises
Options & rights overhang20.9% of shares
In-the-money supplyno data — an exercise price is on record for a minority of the supply
Pending proposed issuesnone

AMPLIA THERAPEUTICS LIMITED's ordinary share count increased by 86.8% from August 2024 to May 2026, reaching 513M shares. Over the past 24 months, the company completed two capital raises totalling A$40.7M, with the most recent being a A$27.6M Placement and Share Purchase Plan in July 2025. Options and rights on issue represent potential for 107M new shares, or 20.9% of the current share count. The nearest expiry for these options is October 2027, and none are currently in the money. As of the June 2026 quarter, the company had A$20.8M in cash, providing approximately 5.4 quarters of operational cover. No proposed securities issues are currently pending.

AI-generated summary of this page's cited filings · updated 11 Sept 2026
Get told when this changes
Set up alerts
Daily email alerts cover risk-level moves, new raises, pending proposed issues and option expiries for the companies you follow.
20.9%
Options & rights overhang
—
In-the-money supply · most strikes not on record
0
Raises · last 12 months
5.4 qtrs
Cash cover · over 4 quarters

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 513.3M per ASX (delayed) (snapshot 11 Sept 2026).
400M450M500MDec 24Oct 25Sept 26Cash raise · 18 July 2025513.3M

Cash runway

5.4 qtrs
More than four quarters of funding at the recent spend rate.
Funds operations to about Oct 2027 at the reported spend rate.
$20.8M cash after burn from the quarter ended 30 June 2026 · Runway is computed from Appendix 4C/5B filings and announced raise proceeds. Filed with the quarterly report: $24.0M cash at quarter end (item 4.6), 6.2 qtrs of funding on the company’s own estimate. Our figure above carries the filed quarter-end balance forward at the reported spend rate and adds announced raise proceeds.
Free account
15 quarters on record — Cash runway history
Quarterly cash, net spend and cover trend from every Appendix 4C/5B on record up to 30 June 2026.
Free account: 2 full company unlocks every month, no card.
Create free accountSee plans

Issuance timeline

Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityOn issue, per this filingSource
9 Sept 20263G · unquotedATX : ORDINARY FULLY PAID513.3MAppendix 3G
15 July 20263G · unquotedATX : ORDINARY FULLY PAID513.3MAppendix 3G
15 July 20263G · unquotedATX : ORDINARY FULLY PAID513.3MAppendix 3G
12 May 20262A · quoted issueATX : ORDINARY FULLY PAID513.3MAppendix 2A
10 Nov 20253G · unquotedATX : ORDINARY FULLY PAID513.1MAppendix 3G
Free account
30 filings on record — Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Free account: 2 full company unlocks every month, no card.
Create free accountSee plans

Capital raises

2 cash raises in the last 24 months · 0 in the last 12 months

every 8.6 monthsaverage gap between raises
13.8 monthssince the most recent
29 Oct 2024 – 18 July 2025first to most recent in this window
$27.6M
Placement and Share Purchase Plan
18 July 2025
Free account
3 raises on record — Full raise history
Issue price, shares issued, brokers and stated purpose for every raise on record.
Free account: 2 full company unlocks every month, no card.
Create free accountSee plans

Forward supply

Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.

Free account
9 dated events on record — Forward supply calendar
Option expiries and proposed issues on one forward timeline, with the securities each could add.
Free account: 2 full company unlocks every month, no card.
Create free accountSee plans

Placement capacity

How much stock a company can place without asking holders. Listing Rule 7.1 allows 15% of ordinary securities in any 12 months, and every Appendix 3B states how much of it an issue uses.

No Appendix 3B in the last 12 months reports an issue under the 15% placement capacity (as at 2026-09-12).
Free account
Placement capacity — LR 7.1 / 7.1A
The filings behind the figure: every Appendix 3B in the window with what it says was issued under 7.1 and 7.1A, each row linked to its filing, and how many shares are left.
Free account: 2 full company unlocks every month, no card.
Create free accountSee plans

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

20.9%
Options & rights overhang · of current shares
—
In-the-money supply · most strikes not on record
107.1M
Potential new shares
Oct 2027
Nearest expiry
What a price move would switch on
53.6M107.1M$0.12 now0.25× today ($0.03) — 0 of the priced supply in the money, 0.0% of shares on issue0.5× today ($0.06) — 0 of the priced supply in the money, 0.0% of shares on issue0.75× today ($0.09) — 0 of the priced supply in the money, 0.0% of shares on issue1× today ($0.12) — 0 of the priced supply in the money, 0.0% of shares on issue1.25× today ($0.15) — 5.0M of the priced supply in the money, 1.0% of shares on issue1.5× today ($0.18) — 5.0M of the priced supply in the money, 1.0% of shares on issue2× today ($0.24) — 11.2M of the priced supply in the money, 2.2% of shares on issue3× today ($0.36) — 12.1M of the priced supply in the money, 2.3% of shares on issue5× today ($0.60) — 12.1M of the priced supply in the money, 2.3% of shares on issue10× today ($1.20) — 12.1M of the priced supply in the money, 2.3% of shares on issue0.25×0.5×0.75×now1.25×1.5×2×3×5×10×

An exercise price is on record for only 11.5% of this supply, so what is in the money today is not a measurement — the tile above reads “—” for that reason. Of the priced supply, 0 is in the money at $0.12 today. No more priced supply until 1.25× today’s price, which takes it to 5.0M (1.0% of shares).

  • Priced supply in the money at the price on the axis — the curve, and the only thing on it. Ten prices, sampled: between two of them the true figure lies between the two.
  • 2.0M (1.8% of the supply above) states a nil exercise price — nothing is paid to convert it, so no share price switches it on or off. It is the flat band, and it is not part of the in-the-money figure.
  • 93.1M (86.9% of the supply above) states no exercise price at all. It cannot be called in or out of the money at any price, which is why it is hatched rather than plotted.
CodeSecurityTypeExercise priceExpiryOn issueSource
ATXOAOptionsPrice-triggered—31 Oct 202790.3MFiling
ATXAAFOptionsPrice-triggered$0.135 June 20285.0MFiling
ATXAFOptionsPrice-triggered$0.1915 July 2028988kFiling
ATXAEOptionsPrice-triggeredNil30 Sept 2028447kFiling
ATXADOptionsPrice-triggered$0.3030 Sept 2028818kFiling
ATXAAIOptionsPrice-triggered$0.2320 Dec 20285.3MFiling
ATXAAJOptionsPrice-triggeredNil1 May 2029240kFiling
ATXAGOptionsPrice-triggeredNil15 July 20311.3MFiling
—OptionsPrice-triggered—9 Sept 20312.8MFiling

“Nil” is a stated nil exercise price: nothing is paid to convert. An em dash means the filing names no exercise price at all. Security is read from the filing’s own class description; an em dash there means the description is not one this table labels. One row is one security class, at the number stated in the most recent quotation application that restated it — linked, and dated, in the last column.

Free account
9 option lines on record — In-the-money value & price ladder
What each line is worth in the money today, the price ladder to the next tranche that converts, and the filing description behind every code.
Free account: 2 full company unlocks every month, no card.
Create free accountSee plans

Director dealings

DateDirectorTypeSharesOptionsOtherValueSource
1 Sept 2025Christopher John BurnsOther4.2M447k——3Y notice
1 Sept 2025Dr. Robert PeachOther placement652k241k535k—3Y notice
1 Sept 2025Jane Catherine BellOther placement130k241k——3Y notice
1 Sept 2025Warwick Bonner TongOther placement152k337k——3Y notice
Free account
4 notices on record — Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Free account: 2 full company unlocks every month, no card.
Create free accountSee plans

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Free account: 2 full company unlocks every month, no card.
Create free account

Latest announcements

9 Sept 2026Notification regarding unquoted securities - ATX
28 Aug 2026Results of Annual General Meeting
27 Aug 2026CEO Managing Director Presentation to Annual General Meeting
6 Aug 2026Bioshares Biotech Summit Presentation
3 Aug 2026$PAmplia signs Collaboration and Supply Agreement with Lilly
30 July 2026Scientific Paper Studies of narmafotinib - Pancreatic Cancer
28 July 2026$PQuarterly Activities/Appendix 4C Cash Flow Report
27 July 2026Notice of Annual General Meeting/Proxy Form
15 July 2026Notification regarding unquoted securities - ATX
15 July 2026Notification regarding unquoted securities - ATX
12 July 2026Amplia Therapeutics Shareholder Webinar
6 July 2026Initial Director's Interest Notice - Brett Carter
5 July 2026Amplia Announces Appointment of Brett Carter to Board
30 June 2026Annual General Meeting to be held Friday 28 August 2026
29 June 2026Amplia Announces Changes to Board's Leadership Roles
24 June 2026Notice of Initial Substantial Holding from SOL
24 June 2026Becoming a substantial holder from PCG
29 May 2026Appendix 4G - Key to Corporate Governance Disclosures
29 May 2026Corporate Governance Statement 2026
29 May 2026$PPreliminary Final Report and Annual Report YE 31 March 2026

Headlines link to the source PDFs on the ASX announcements platform. Data as of 12 Sept 2026.